KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Return on Invested Capital (2018 - 2025)

Guardant Health's Return on Invested Capital history spans 8 years, with the latest figure at 1.92% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 253.0% year-over-year to 1.92%; the TTM value through Dec 2025 reached 1.92%, down 253.0%, while the annual FY2025 figure was 3.65%, 5039.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 1.92% at Guardant Health, up from 1.34% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 16.7% in Q3 2024 and bottomed at 71.18% in Q1 2023.
  • The 5-year median for Return on Invested Capital is 0.67% (2021), against an average of 4.13%.
  • The largest annual shift saw Return on Invested Capital plummeted -7046bps in 2023 before it surged 6650bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.61% in 2021, then tumbled by -691bps to 4.81% in 2022, then skyrocketed by 39bps to 2.92% in 2023, then soared by 252bps to 4.45% in 2024, then tumbled by -57bps to 1.92% in 2025.
  • Per Business Quant, the three most recent readings for GH's Return on Invested Capital are 1.92% (Q4 2025), 1.34% (Q3 2025), and 1.66% (Q2 2025).